Danaher Corporation (DHR) Presents at Jefferies London Healthcare Conference 2025 Transcript

Core Insights - The company reported a strong performance in the third quarter, exceeding expectations in revenue, earnings, and cash flow, which positions it well for future growth [2] - Core growth for the third quarter was 3%, but the company achieved over 10% growth in earnings per share, indicating strong earnings potential despite moderate growth rates [3] Financial Performance - The company beat third-quarter expectations on both the top and bottom lines, leading to a reinvestment in productivity initiatives for the fourth quarter [2] - The earnings power of the portfolio is highlighted by the ability to deliver significant earnings expansion even with a core growth rate of 3% [3] Future Outlook - The company has set an initial framework for 2026, projecting a core growth range of 3% to 6%, indicating a cautious but optimistic outlook for the upcoming years [1]